A detailed history of Cedar Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cedar Wealth Management, LLC holds 290 shares of MRNA stock, worth $10,686. This represents 0.01% of its overall portfolio holdings.

Number of Shares
290
Previous 290 -0.0%
Holding current value
$10,686
Previous $34,000 44.12%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $7,683 - $10,389
90 Added 45.0%
290 $30,000
Q3 2023

Oct 27, 2023

BUY
$96.41 - $126.61 $19,282 - $25,322
200 New
200 $20,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cedar Wealth Management, LLC Portfolio

Follow Cedar Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Wealth Management, LLC with notifications on news.